Skip to main content
. 2015 Mar 30;6(11):8929–8946. doi: 10.18632/oncotarget.3369

Figure 2. Knockdown of EphB1 reduces medulloblastoma cell viability and cell growth, and alters cell cycle progression.

Figure 2

(A) EphB1 knockdown results in a significant decrease in live cell count as assessed by the trypan blue dye exclusion assay (n = 3, *p ≤ 0.01; **p < 0.001). (B) Knockdown of EphB1 results in an approximately 26% decrease in cell growth as quantified by MTT assay (n = 2, **p < 0.001). (C) Knockdown of EphB1 increases percentage of cells in G1 phase (n ≥ 2). Data shown are average ± standard error from independent experiments. Normalized values are shown in Figure 2B.